Cheng Liu

This inventor holds 17 USPTO granted patents and 9 published patent applications and 6 EPO patents, primarily in Biomolecular Engineering. Top assignees: Nuvolta Technologies (Shanghai) Co., Ltd., Chinese Academy of Sciences, Huawei Technologies Co., Limited. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cheng Liu. Retrieved from https://idiyas.com/inventor/cheng-liu-le1k4gak

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 (Patent Applications = 9)

% Patents Active = 100.0

EPO Patents = 6 (Patent Applications = 16)

Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 4(Granted Patents)

Location History:

Nanjing, CN (2019)
Shanghai, CN (2015 - 2024)

Company Filing History:

3 out of 4

Nuvolta Technologies (Shanghai) Co., Ltd.

patents

2 out of 3,363

Chinese Academy of Sciences

patents

2 out of 27,557

Huawei Technologies Co., Limited

patents

4. 2 out of 3

Shanghai Sundise Chinese Medicine Technology Development Co., Ltd

patents

5. 2 out of 2

Yafei (Shanghai) Biopharmaceutical Co., Ltd.

patents

6. 1 out of 42

Nuvolta Technologies (Hefei) Co., Ltd.

patents

7. 1 out of 1

Shanghai Huanghai Pharmaceutical Co., Ltd.

patent

8. 1 out of 94

Shanghai Yanfeng Jinqiao Automotive Trim Systems Co. Ltd.

patents

9. 1 out of 29,901

Texas Instruments Corporation

patents

10. 1 out of 1

Yafei Shanghai Biolog Medicine Science & Technolog

patent

11. 1 out of 1

Yafei Shanghai Biology Medicine Science & Technology Co. Ltd.

patent

12. 1 out of 14

Yanfeng International Automotive Technology Co., Ltd.

patents

where one patent can have more than one assignee

Years Active: 2015-2026

Loading Chart...

Areas of Expertise:

Biomolecule Conjugates

Phase Imaging

Battery Charging

Vehicle Components

Switched Capacitor Converter

Power Conversion

Immune-Stimulating Complex

Kinase Inhibitor

Cyanophycean Treatment

Pharmaceutical Preparation

Medicinal Composition

Doxorubicin Derivative

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12564632 - Conjugates of Biomolecule and Use Thereof (2026-03-03),

2. 12372414 - Device and method for phase imaging and element detection based on wavefront modulation (2025-07-29),

3. 12275364 - Steering wheel component and steering wheel assembly (2025-04-14),

4. 12217069 - Operation sequence adding method, electronic device, and system (2025-02-04),

5. 12160131 - Battery charging apparatus and method thereof (2024-12-03),

6. 11912227 - Component for vehicle interior (2024-02-27),

7. 11736035 - Switched capacitor converter and method thereof (2023-08-22),

8. 11695334 - Switched capacitor converter mode transition control method (2023-07-04),

9. 11588391 - Power conversion structure, system, method, electronic device including power conversion structure, and chip unit (2023-02-21),

10. 11509227 - Active clamp flyback converter (2022-11-22),

11. 11319341 - Immune-stimulating soluble doxorubicin-conjugated complex (2022-05-03),

12. 11078232 - Preparation and use of molecular site targeted and activated kinase inhibitor (2021-08-03),

13. 10494278 - Method for in-situ harmless treatment of cyanophycean accumulation and suspended solids in lakeside wetlands (2019-12-03),

14. 10412057 - Service access method and system, and apparatus (2019-09-10),

15. 9982011 - Legumain activated doxorubicin derivative as well as preparation method and application thereof (2018-05-29),

Title: Cheng Liu: Pioneering Inventor from Shanghai

Introduction: Cheng Liu is a renowned inventor hailing from Shanghai, China, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Cheng Liu holds several patents in various technological domains, including artificial intelligence, robotics, and renewable energy solutions.

Career Highlights: With a career spanning over two decades, Cheng Liu has worked with leading tech companies and research institutions, spearheading projects that have revolutionized industries worldwide.

Collaborations: Throughout his career, Cheng Liu has collaborated with top engineers, scientists, and researchers, fostering a culture of innovation and excellence in all his projects.

Conclusion: Cheng Liu's relentless pursuit of innovation and his passion for creating cutting-edge solutions have solidified his position as a trailblazer in the world of technology.

Profile summary based on public USPTO records.